Northern Trust’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,142
| Closed | -$11.4K | – | 4560 |
|
|
2024
Q4 | $11.4K | Hold |
27,142
| – | – | ﹤0.01% | 4417 |
|
|
2024
Q3 | $53.5K | Sell |
27,142
-11,737
| -30% | -$44.5K | ﹤0.01% | 4190 |
|
|
2024
Q2 | $208K | Buy |
+38,879
| New | +$162K | ﹤0.01% | 3855 |
|
|
2023
Q4 | – | Sell |
-5,020
| Closed | -$111K | – | 4566 |
|
|
2023
Q3 | $111K | Buy |
5,020
+4,829
| +2,528% | +$126K | ﹤0.01% | 3987 |
|
|
2023
Q2 | $1.35K | Hold |
191
| – | – | ﹤0.01% | 4530 |
|
|
2023
Q1 | $8.8K | Buy |
+191
| New | +$20.8K | ﹤0.01% | 4535 |
|
|
2022
Q4 | – | Sell |
-52
| Closed | -$29K | – | 4721 |
|
|
2022
Q3 | $29K | Hold |
52
| – | – | ﹤0.01% | 4471 |
|
|
2022
Q2 | $42K | Sell |
52
-4
| -7% | -$5.93K | ﹤0.01% | 4457 |
|
|
2022
Q1 | $147K | Hold |
56
| – | – | ﹤0.01% | 4233 |
|
|
2021
Q4 | $144K | Hold |
56
| – | – | ﹤0.01% | 4310 |
|
|
2021
Q3 | $256K | Hold |
56
| – | – | ﹤0.01% | 4071 |
|
|
2021
Q2 | $333K | Hold |
56
| – | – | ﹤0.01% | 3887 |
|
|
2021
Q1 | $453K | Buy |
56
+2
| +4% | +$21.2K | ﹤0.01% | 3845 |
|
|
2020
Q4 | $335K | Buy |
54
+6
| +13% | +$36.7K | ﹤0.01% | 3825 |
|
|
2020
Q3 | $329K | Buy |
48
+6
| +14% | +$44.5K | ﹤0.01% | 3696 |
|
|
2020
Q2 | $269K | Buy |
42
+15
| +56% | +$63.7K | ﹤0.01% | 3690 |
|
|
2020
Q1 | $88K | Buy |
27
+10
| +59% | +$41.6K | ﹤0.01% | 3849 |
|
|
2019
Q4 | $97K | Hold |
17
| – | – | ﹤0.01% | 3942 |
|
|
2019
Q3 | $208K | Sell |
17
-53
| -76% | -$425K | ﹤0.01% | 3759 |
|
|
2019
Q2 | $589K | Sell |
70
-4
| -5% | -$46.9K | ﹤0.01% | 3515 |
|
|
2019
Q1 | $970K | Buy |
74
+1
| +1% | +$17K | ﹤0.01% | 3370 |
|
|
2018
Q4 | $1.1M | Sell |
73
-1
| -1% | -$23.5K | ﹤0.01% | 3334 |
|
|
2018
Q3 | $2.74M | Buy |
74
+12
| +19% | +$395K | ﹤0.01% | 3041 |
|
|
2018
Q2 | $2.42M | Buy |
62
+51
| +464% | +$1.94M | ﹤0.01% | 3102 |
|
|
2018
Q1 | $353K | Buy |
11
+1
| +10% | +$26.9K | ﹤0.01% | 3656 |
|
|
2017
Q4 | $198K | Buy |
10
+1
| +11% | +$20.6K | ﹤0.01% | 3821 |
|
|
2017
Q3 | $188K | Sell |
9
-1
| -10% | -$18.6K | ﹤0.01% | 3814 |
|
|
2017
Q2 | $153K | Sell |
10
-25
| -71% | -$501K | ﹤0.01% | 3875 |
|
|
2017
Q1 | $925K | Hold |
35
| – | – | ﹤0.01% | 3371 |
|
|
2016
Q4 | $916K | Sell |
35
-1
| -3% | -$30.8K | ﹤0.01% | 3378 |
|
|
2016
Q3 | $1.29M | Buy |
36
+1
| +3% | +$32.8K | ﹤0.01% | 3268 |
|
|
2016
Q2 | $1.4M | Buy |
35
+8
| +30% | +$361K | ﹤0.01% | 3222 |
|
|
2016
Q1 | $1.32M | Buy |
27
+1
| +4% | +$44.2K | ﹤0.01% | 3161 |
|
|
2015
Q4 | $1.42M | Buy |
26
+3
| +13% | +$162K | ﹤0.01% | 3198 |
|
|
2015
Q3 | $990K | Buy |
23
+8
| +53% | +$532K | ﹤0.01% | 3320 |
|
|
2015
Q2 | $1.24M | Buy |
15
+1
| +7% | +$86.8K | ﹤0.01% | 3262 |
|
|
2015
Q1 | $1.06M | Buy |
14
+2
| +17% | +$186K | ﹤0.01% | 3382 |
|
|
2014
Q4 | $1.15M | Buy |
12
+9
| +300% | +$742K | ﹤0.01% | 3347 |
|
|
2014
Q3 | $262K | Buy |
+3
| New | +$279K | ﹤0.01% | 3750 |
|
Northern Trust's TTOO Position: Q1 2025 in Review
Northern Trust sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 27,142 shares — an estimated $11.4K sold.
Northern Trust first reported a position in TTOO in Q3 2014 and held it in 39 quarters. The position peaked at $2.74M in Q3 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Northern Trust reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Northern Trust sold 27,142 T2 Biosystems, Inc shares in Q1 2025, an estimated $11.4K.
- Northern Trust first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 39 quarters.
- Northern Trust's T2 Biosystems, Inc position peaked at $2.74M in Q3 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.